Research analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research report issued on Saturday. The firm set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
Calithera Biosciences stock opened at $0.00 on Friday. Calithera Biosciences has a 12-month low of $0.00 and a 12-month high of $0.12.
Calithera Biosciences Company Profile
Further Reading
- Five stocks we like better than Calithera Biosciences
- What is Insider Trading? What You Can Learn from Insider Trading
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- What is Forex and How Does it Work?
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- 3 Ways To Invest In Coffee, Other Than Drinking It
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
